Toll-like receptor 4–mediated enteric glia loss is critical for the development of necrotizing enterocolitis
Mark L. Kovler, Andres Salazar, William B. Fulton, Peng Lü, Yukihiro Yamaguchi, Qinjie Zhou, Maame Efua Sampah, Asuka Ishiyama, Thomas Prindle, Sanxia Wang, Hongpeng Jia, Peter Wipf, Chhinder P. Sodhi, David J. Hackam
Abstract
) did not show NEC-induced enteric glia depletion and were protected from NEC. Mechanistically, brain-derived neurotrophic factor (BDNF) from enteric glia restrained TLR4 signaling on the intestine to prevent NEC. BDNF was reduced in mouse and human NEC, and BDNF administration reduced both TLR4 signaling and NEC severity in enteric glia–deficient mice. Last, we identified an agent (J11) that enhanced enteric glial BDNF release, inhibited intestinal TLR4, restored motility, and prevented NEC in mice. Thus, enteric glia loss might contribute to NEC through intestinal dysmotility and increased TLR4 activation, suggesting enteric glia therapies for this disorder.